Prospective observational study II on the prognosis of patients with unresectable advanced gastroenteral and pancreatic neuroendocrine tumors in Japan

Prospective observational study II on the prognosis of patients with unresectable advanced gastroenteral and pancreatic neuroendocrine tumors in Japan - Prospective observational study II on the prognosis of patients with unresectable advanced gastroenteral and pancreatic neuroendocrine tumors in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015976

Enrollment

200

Registered

2014-12-17

Start date

2014-12-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable advanced gastroenteral and pancreatic neuroendocrine tumors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) pathologicaly proven neuroendocrine tumors (NET) as G1/G2, NEC or MANEC 2) unresectable NET or reccurent one after curative resection diagnosed after institutional IRB/IEC approval 3) gastroenteral or pancreatic NET 4) age < 80 5) written informed consent provided from subject (if patients are less than 20 years old, written informed consent provided from their legal representatives is also required)

Exclusion criteria

Exclusion criteria: 1) previously treatment of NET excent for curative resection, neoadjuvant therapy or adjuvant therapy within 1 year before the diagnosis of unresectable NET or reccurent one after curative resection 2) concurrent multiple malignancies 3) resectable reccurent NET after curative resection 4) previously enrolled subject 5) Patients regarded as ineligible for other reason by the investigator.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
progression-free survival	—

Countries

Japan

Contacts

Public ContactFujimori Nao

Kyushu University Hospital Clinical Education Center

fujimori@intmed3.med.kyushu-u.ac.jp092-642-5221

Outcome results